Aspiriant LLC’s Honeywell HON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $765K | Buy |
3,385
+1,904
| +129% | +$435K | 0.02% | 177 |
|
|
2025
Q4 | $289K | Buy |
1,481
+18
| +1% | +$3.52K | 0.01% | 284 |
|
|
2025
Q3 | $290K | Sell |
1,463
-383
| -21% | -$80K | 0.01% | 255 |
|
|
2025
Q2 | $405K | Sell |
1,846
-379
| -17% | -$76.7K | 0.01% | 222 |
|
|
2025
Q1 | $444K | Sell |
2,225
-438
| -16% | -$88.6K | 0.02% | 197 |
|
|
2024
Q4 | $567K | Buy |
2,663
+416
| +19% | +$86.8K | 0.02% | 180 |
|
|
2024
Q3 | $438K | Buy |
2,247
+737
| +49% | +$143K | 0.02% | 197 |
|
|
2024
Q2 | $304K | Sell |
1,510
-1,102
| -42% | -$210K | 0.01% | 226 |
|
|
2024
Q1 | $505K | Hold |
2,612
| – | – | 0.02% | 198 |
|
|
2023
Q4 | $516K | Sell |
2,612
-22
| -0.8% | -$3.97K | 0.02% | 185 |
|
|
2023
Q3 | $459K | Buy |
2,634
+184
| +8% | +$33.7K | 0.02% | 187 |
|
|
2023
Q2 | $479K | Buy |
2,450
+414
| +20% | +$76.9K | 0.02% | 181 |
|
|
2023
Q1 | $367K | Sell |
2,036
-68
| -3% | -$12.8K | 0.02% | 199 |
|
|
2022
Q4 | $425K | Buy |
2,104
+116
| +6% | +$22.2K | 0.02% | 189 |
|
|
2022
Q3 | $314K | Buy |
1,988
+151
| +8% | +$26.3K | 0.02% | 207 |
|
|
2022
Q2 | $302K | Buy |
1,837
+313
| +21% | +$56.2K | 0.01% | 210 |
|
|
2022
Q1 | $280K | Sell |
1,524
-167
| -10% | -$30.9K | 0.02% | 231 |
|
|
2021
Q4 | $331K | Buy |
1,691
+35
| +2% | +$7.07K | 0.02% | 223 |
|
|
2021
Q3 | $332K | Sell |
1,656
-384
| -19% | -$81.9K | 0.02% | 186 |
|
|
2021
Q2 | $422K | Buy |
2,040
+420
| +26% | +$88.8K | 0.02% | 169 |
|
|
2021
Q1 | $332K | Sell |
1,620
-73
| -4% | -$14.3K | 0.02% | 171 |
|
|
2020
Q4 | $340K | Buy |
1,693
+80
| +5% | +$14.5K | 0.02% | 162 |
|
|
2020
Q3 | $250K | Sell |
1,613
-168
| -9% | -$25K | 0.02% | 193 |
|
|
2020
Q2 | $243K | Sell |
1,781
-123
| -6% | -$16.3K | 0.02% | 166 |
|
|
2020
Q1 | $240K | Sell |
1,904
-1,233
| -39% | -$190K | 0.02% | 168 |
|
|
2019
Q4 | $522K | Sell |
3,137
-197
| -6% | -$32.2K | 0.05% | 134 |
|
|
2019
Q3 | $532K | Sell |
3,334
-82
| -2% | -$13K | 0.05% | 143 |
|
|
2019
Q2 | $562K | Sell |
3,416
-46
| -1% | -$7.32K | 0.05% | 140 |
|
|
2019
Q1 | $519K | Sell |
3,462
-61
| -2% | -$8.52K | 0.04% | 144 |
|
|
2018
Q4 | $439K | Buy |
3,523
+97
| +3% | +$13.2K | 0.03% | 152 |
|
|
2018
Q3 | $514K | Sell |
3,426
-265
| -7% | -$37.6K | 0.04% | 155 |
|
|
2018
Q2 | $480K | Buy |
3,691
+1,734
| +89% | +$231K | 0.04% | 161 |
|
|
2018
Q1 | $255K | Buy |
+1,957
| New | +$271K | 0.02% | 209 |
|
|
2017
Q4 | – | Sell |
-1,904
| Closed | -$244K | – | 120 |
|
|
2017
Q3 | $244K | Buy |
+1,904
| New | +$236K | 0.02% | 181 |
|
Other funds holding HON
VCM
VPM
Aspiriant LLC's HON Position: Q1 2026 in Review
Aspiriant LLC increased its Honeywell (HON) stake by 129% in Q1 2026, buying an estimated $435K and bringing the position to 3,385 shares worth $765K. The position accounts for 0.02% of the portfolio, ranked #177.
Aspiriant LLC first reported a position in HON in Q3 2017 and has held it in 34 quarters since. 2,793 funds tracked by Wall St. Rank hold HON as of Q1 2026.
- Aspiriant LLC held 3,385 shares of Honeywell worth $765K as of Q1 2026.
- Aspiriant LLC bought 1,904 Honeywell shares in Q1 2026, an estimated $435K.
- Honeywell made up 0.02% of Aspiriant LLC's portfolio in Q1 2026, its #177 holding.
- Aspiriant LLC first reported a position in Honeywell in Q3 2017 and has held it in 34 quarters since.
- 2,793 funds tracked by Wall St. Rank held Honeywell as of Q1 2026.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.